The Microarray Kits Market is projected to reach $2.51 billion by 2031, at a CAGR of 5.8% from 2024 to 2031. Microarray kits are used in the detection and quantification of a large number of nucleic acids from biological samples, such as cells, tissues, or bodily fluids. The commercially available microarray kits are deployed in the assessment of protein families, probing serum for diagnostic information, profiling expression in response to drugs, and profiling cells treated with certain stimulators or transfected with a given gene.
The growth of the microarray kits market is driven by several factors, including the increasing research applications of microarrays, the use of microarrays in cancer research, the increasing adoption of personalized medicine, and the growing R&D expenditure in the pharmaceutical and biotechnology industries. Factors such as technological advancements in microarray technology and emerging economies are a few of the opportunities for market growth. Lack of sensitivity and accuracy is challenging the market growth. However, the higher costs of microarrays, as compared to other genetic methods, restrain the growth of the market.
Microarray is a laboratory technique used in the high-throughput analysis of many biological molecules, such as DNA, RNA, proteins, or antibodies, in a single experiment. Microarrays are powerful tools that can assess the presence, abundance, or activity of multiple molecules within a complex biological sample. Microarrays are used in various fields of research, such as genomics and molecular biology, detection, and quantification of proteins, antibodies, or other biomolecules, and cancer research, among others.
Some of the recent advances in the microarray techniques are as follows:
Such developments in the field of microarray technology provide several benefits, such as personalized services for patients as per their condition, rapid and accurate results, and high-quality data. These advancements can be applied in various aspects of the research and diagnostic field, such as clinical trials, research studies, drug discovery, biomarker discovery, and diagnosis and treatment of diseases, supporting market growth.
Click here to: Get Free Sample Pages of this Report
Microarray technology refers to the approach that involves the binding of an array of millions of nucleic acid fragments to a solid surface, which is generally referred to as a chip. A DNA or RNA sample is then added to the chip in order to initiate complementary base pairing when the immobilized fragments on the chip produce light through fluorescence that is detected using a specialized device. Microarray technology allows genomic analysis without sequencing and also greatly reduces the cost of performing experiments across the fields of biology and biomedicine. Initially, microarray technology was only used to measure gene expression or quantify certain small molecules. However, due to new and innovative advancements, modern microarray technology is a fast and reliable solution for a variety of other fields, such as biomarker and drug discovery.
Research applications include clinical trials and drug discoveries using microarray technologies for various purposes, such as gene expression, detection of DNA sequences, studying gene mutations, and incidence of certain biomarkers as well. It can be used as a genomic tool to study and compare different features of the genome based on different diseases and conditions. Due to the study of genomics and data acquired using the technology, population-based studies can also be carried out easily.
In January 2024, Thermo Fisher Scientific, Inc. (U.S.) launched the Axiom PangenomiX Array, which is used for research applications and combines four assays in one test: SNP genotyping, whole-genome copy number variant detection, fixed copy number discovery, and blood and HLA typing. Some of the research areas where it is used include genome-wide association studies (GWAS), population health initiatives, polygenic risk score research and development, and clinical research for trials in drug discovery.
This technology is also used in pharmacogenomics by facilitating the analysis of gene expression patterns and genetic variations to understand how individuals respond to drugs. It is also used to identify which genes are activated or deactivated in response to specific drugs. Comparing gene expression profiles between individuals, researchers can predict variations in drug response. There has been a significant rise in the use of microarrays in pharmacogenomic programs. For instance, the Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment (PREDICT) program was implemented by the Vanderbilt University Medical Center (U.S.). It utilizes panel-based genotyping to identify specific SNPs associated with drug responses, enabling tailored clinical decision support for each participant. This highlights the crucial role of microarray technologies in advancing personalized approaches within pharmacogenomics.
Among product types, in 2024, the DNA microarray kits segment is expected to account for the largest share of the market. DNA microarrays, also known as DNA chips or gene chips, are used in genomics and molecular biology for the simultaneous analysis of thousands to millions of DNA sequences, typically genes or oligonucleotide probes, on a small, solid support surface. The large market share of the segment is attributed to factors such as increasing incidence of cancer, wide application areas of microarray technology, rising funding for genomic R&D, and growing research for personalized medicine. For instance, the Genomics Research and Development Initiative (GDRI) (Canada) receives close to USD 20 million from the Government of Canada annually, to carry out vital genomics research.
Among applications, in 2024, the drug discovery & development segment is expected to account for the largest share of the market. The large share of the segment is attributed to factors such as the growing public and private investments for pharmaceutical and biotech research & development, initiatives by the pharmaceutical and biotech companies to expand their research capabilities by opening new research centers, and launches of new and innovative microarray kits and technologies. In December 2023, the National Institutes of Health (NIH) (U.S.) awarded USD 6.4 million to fund research at colleges and universities that have not received significant funding from the NIH recently in order to establish Diversity Centers for genome research. This will increase the number of research centers, which will increase the biomedical research being conducted, therefore, increasing the use of innovative technologies such as microarrays, driving the growth of the segment.
Among end users, in 2024, the pharmaceutical & biotechnology companies’ segment is expected to account for the largest share of the market. The large share of the segment is attributed to factors such as high pharmaceutical R&D expenditure, rising demand for new drug discovery & development, increasing funding, grants, and investments for genomic research, and growing focus on increasing overall productivity. The rising demand for drug discovery coupled with the rising R&D expenditure will increase the demand for techniques such as microarray technology that offer accurate results and provide better and vast information.
The largest share of the segment is primarily due to the availability of advanced infrastructure for genomic research, the presence of key players, the presence of key pharmaceutical companies and research institutes, availability of funding for life science research. The presence of key players in the market improves the accessibility to advanced microarray technology resources, including kits.
The key players profiled in the microarray kits market report are Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Edvotek, Inc. (U.S.), Sakura Finetek USA, Inc. (U.S.), Dextra Laboratories Ltd. (U.K.), and GeneCopoeia, Inc. (U.S.).
The report includes a competitive landscape based on an extensive assessment of the market based on product type, application, and end user. The report also provides insights into the presence of major market players and their key growth strategies in the last three to four years.
|
Particular |
Details |
|
Page No |
~220 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
5.8% |
|
Market Size (Value) |
$2.51 billion by 2031 |
|
Segments Covered |
By Product Type
By Application
By End User
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa |
|
Key Companies |
Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Edvotek, Inc. (U.S.), Sakura Finetek USA, Inc. (U.S.), Dextra Laboratories Ltd. (U.K.), and GeneCopoeia, Inc. (U.S.). |
This market study covers the market sizes & forecasts of the microarray kits based on product type, application, end user, and geography. This market study also provides the value analysis of various segments and sub-segments of the global microarray kits market at country levels.
The microarray kits market is projected to reach $2.51 billion by 2031, at a CAGR of 5.8% during the forecast period.
The DNA microarray kits segment is expected to account for the largest share of the market in 2024. Factors such as wide application areas of microarrays, rising funding for genomic R&D, and the growing research for personalized medicine and the use of microarrays for the same.
The drug discovery & development segment is expected to account for the largest share of the microarray kits market in 2024. The largest share of this segment is attributed to factors such as growing public and private investments in pharmaceutical and biotech research & development and initiatives by the pharmaceutical and biotech companies to expand their research capabilities by opening new research centers and launching new and innovative microarray kits and technologies.
The pharmaceutical & biotechnology companies’ segment is expected to account for the largest share of the microarray kits market. The largest share of this segment is attributed to factors such as high pharmaceutical R&D expenditure, rising demand for new drug discovery & development, and growing focus on increasing overall productivity.
The growth of the microarray kits market is driven by several factors, including the increasing research applications of microarrays, the use of microarrays in cancer research, the increasing adoption of personalized medicine, and the growing R&D expenditure in pharmaceutical & biotechnology industries. Furthermore, technological advancements in microarray technology and emerging economies serve as major opportunities for the existing market players and new entrants in the microarray kits market.
The key players profiled in the microarray kits market report are Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Edvotek, Inc. (U.S.), Sakura Finetek USA, Inc. (U.S.), Dextra Laboratories Ltd. (U.K.), and GeneCopoeia, Inc. (U.S.).
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumption for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Research Applications of Microarrays
4.2.2. Use of Microarrays in Cancer Research
4.2.3. Increasing Adoption of Personalized Medicine
4.2.4. Growing R&D Expenditure in Pharmaceutical and Biotechnology Industries
4.3. Restraints
4.3.1. Higher Costs of Microarrays as Compared to Other Genetic Testing Methods
4.4. Opportunities
4.4.1. Technological Advancements in Microarray Technology
4.4.2. Emerging Economies
4.5. Challenges
4.5.1. Lack of Sensitivity and Accuracy
4.6. Trends
4.7. Regulatory Scenario
4.8. Pricing Analysis
4.9. Value Chain Analysis
5. Global Microarray Kits Market—by Product Type
5.1. Overview
5.2. DNA Microarray Kits
5.2.1. cDNA Microarray Kits
5.2.2. Oligo Microarray Kits
5.2.3. BAC Microarray Kits
5.2.4. SNP Microarray Kits
5.3. RNA Microarray Kits
5.4. Protein Microarray Kits
5.5. Tissue Microarray Kits
6. Global Microarray Kits Market—by Application
6.1. Overview
6.2. Drug Discovery & Development
6.3. Research Applications
6.4. Diagnostics
6.5. Other Applications
7. Global Microarray Kits Market—by End User
7.1. Overview
7.2. Pharmaceutical & Biotechnology Companies
7.3. Contract Research Organizations
7.4. Research & Academic Institutes
7.5. Hospitals & Diagnostic Laboratories
7.6. Other End Users (Veterinary Clinics, Agricultural Industry, Forensic Laboratories)
8. Microarray Kits Market—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Rest of Asia Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Market Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis/Market Ranking, By Key Players (2022)
10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. Thermo Fisher Scientific, Inc.
10.2. Illumina, Inc.
10.3. Agilent Technologies, Inc.
10.4. Merck KgaA
10.5. PerkinElmer, Inc.
10.6. QIAGEN N.V.
10.7. Edvotek Inc.
10.8. Sakura Finetek USA, Inc.
10.9. Dextra Laboratories Ltd
10.10. GeneCopoeia, Inc.
10.11. Other Companies
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Global Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 2 Global DNA Microarray Kits Market, by Type, 2022–2031 (USD Million)
Table 3 Global DNA Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global cDNA Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Oligo Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global BAC Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global SNP Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global RNA Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Protein Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Tissue Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 12 Global Microarray Kits Market for Drug Discovery & Development, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Microarray Kits Market for Research Applications, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Microarray Kits Market for Diagnostics, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Microarray Kits Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 17 Global Microarray Kits Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Microarray Kits Market for Contract Research Organizations, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Microarray Kits Market for Research & Academic Institutes, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Microarray Kits Market for Hospital & Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Microarray Kits Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 23 North America: Microarray Kits Market, by Country, 2022–2031 (USD Million)
Table 24 North America: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 25 North America: DNA Microarray Market, by Type, 2022–2031 (USD Million)
Table 26 North America: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 27 North America: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 28 U.S.: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 29 U.S.: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 30 U.S.: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 31 U.S.: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 32 Canada: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 33 Canada: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 34 Canada: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 35 Canada: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 36 Europe: Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 37 Europe: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 38 Europe: DNA Microarray Market, by Type, 2022–2031 (USD Million)
Table 39 Europe: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 40 Europe: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 41 Germany: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 42 Germany: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 43 Germany: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 44 Germany: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 45 France: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 46 France: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 47 France: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 48 France: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 49 U.K.: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 50 U.K.: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 51 U.K.: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 52 U.K.: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 53 Italy: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 54 Italy: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 55 Italy: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 56 Italy: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 57 Spain: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 58 Spain: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 59 Spain: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 60 Spain: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 61 Rest of Europe: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 62 Rest of Europe: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 63 Rest of Europe: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 64 Rest of Europe: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 65 Asia-Pacific: Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 66 Asia-Pacific: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 67 Asia-Pacific: DNA Microarray Market, by Type, 2022–2031 (USD Million)
Table 68 Asia-Pacific: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 69 Asia-Pacific: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 70 Japan: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 71 Japan: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 72 Japan: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 73 Japan: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 74 China: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 75 China: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 76 China: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 77 China: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 78 India: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 79 India: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 80 India: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 81 India: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 82 Rest of Asia-Pacific: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 83 Rest of Asia-Pacific: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 84 Rest of Asia-Pacific: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 85 Rest of Asia-Pacific: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 86 Latin America: Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 87 Latin America: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 88 Latin America: DNA Microarray Market, by Type, 2022–2031 (USD Million)
Table 89 Latin America: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 90 Latin America: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 91 Brazil: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 92 Brazil: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 93 Brazil: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 94 Brazil: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 95 Mexico: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 96 Mexico: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 97 Mexico: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 98 Mexico: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 99 Rest of Latin America: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 100 Rest of Latin America: DNA Microarrays Market, by Type, 2022–2031 (USD Million)
Table 101 Rest of Latin America: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 102 Rest of Latin America: Microarray Kits Market, by End User, 2022–2031 (USD Million)
Table 103 Middle East & Africa: Microarray Kits Market, by Country/Region, 2022–2031 (USD Million)
Table 104 Middle East & Africa: Microarray Kits Market, by Product Type, 2022–2031 (USD Million)
Table 105 Middle East & Africa: DNA Microarray Market, by Type, 2022–2031 (USD Million)
Table 106 Middle East & Africa: Microarray Kits Market, by Application, 2022–2031 (USD Million)
Table 107 Middle East & Africa: Microarray Kits Market, by End User, 2022–2031 (USD Million)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Global Microarray Kits Market, by Product Type, 2024 VS. 2031 (USD Million)
Figure 8 Global Microarray Kits Market, by Application, 2024 VS. 2031 (USD Million)
Figure 9 Global Microarray Kits Market, by Applications, 2024 VS. 2031 (USD Million)
Figure 10 Microarray Kits Market, by Geography
Figure 11 Global Microarray Kits Market, by Product Type, 2024 VS. 2031 (USD Million)
Figure 12 Global Microarray Kits Market, by Application, 2024 VS. 2031 (USD Million)
Figure 13 Global Microarray Kits Market, by End User, 2024 VS. 2031 (USD Million)
Figure 14 Global Microarray Kits Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 15 North America: Microarray Kits Market Snapshot
Figure 16 Europe: Microarray Kits Market Snapshot
Figure 17 Asia-Pacific: Microarray Kits Market Snapshot
Figure 18 Latin America: Microarray Kits Market Snapshot
Figure 19 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 20 Global Microarray Kits Market: Competitive Dashboard
Figure 21 Global Microarray Kits Market: Competitive Benchmarking, by Product Type
Figure 22 Global Microarray Kits Market: Market Share Analysis/Market Ranking (2023)
Figure 23 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 24 Illumina, Inc.: Financial Overview (2022)
Figure 25 Agilent Technologies, Inc.: Financial Overview (2023)
Figure 26 Merck KGaA: Financial Overview (2022)
Figure 27 PerkinElmer, Inc.: Financial Overview (2022)
Figure 28 QIAGEN N.V.: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Oct-2023
Published Date: May-2023
Published Date: Nov-2019
